
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Wnt/beta‐catenin signaling and its modulators in nonalcoholic fatty liver diseases
Karthik Shree Harini, Devaraj Ezhilarasan
Hepatobiliary & pancreatic diseases international (2022) Vol. 22, Iss. 4, pp. 333-345
Closed Access | Times Cited: 26
Karthik Shree Harini, Devaraj Ezhilarasan
Hepatobiliary & pancreatic diseases international (2022) Vol. 22, Iss. 4, pp. 333-345
Closed Access | Times Cited: 26
Showing 1-25 of 26 citing articles:
Molecular mechanisms in thioacetamide-induced acute and chronic liver injury models
Devaraj Ezhilarasan
Environmental Toxicology and Pharmacology (2023) Vol. 99, pp. 104093-104093
Closed Access | Times Cited: 42
Devaraj Ezhilarasan
Environmental Toxicology and Pharmacology (2023) Vol. 99, pp. 104093-104093
Closed Access | Times Cited: 42
Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets
Yinshuang Chen, Weipeng Wang, Maria P. Morgan, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 27
Yinshuang Chen, Weipeng Wang, Maria P. Morgan, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 27
Thyromimetics and MASLD: Unveiling the Novel Molecules Beyond Resmetirom
Devaraj Ezhilarasan
Journal of Gastroenterology and Hepatology (2025)
Closed Access | Times Cited: 1
Devaraj Ezhilarasan
Journal of Gastroenterology and Hepatology (2025)
Closed Access | Times Cited: 1
Gene Polymorphisms and Biological Effects of Vitamin D Receptor on Nonalcoholic Fatty Liver Disease Development and Progression
Evanthia Tourkochristou, Αthanasia Mouzaki, Christos Triantos
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8288-8288
Open Access | Times Cited: 15
Evanthia Tourkochristou, Αthanasia Mouzaki, Christos Triantos
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8288-8288
Open Access | Times Cited: 15
Flavonoids-based nanomedicines for the treatment of liver fibrosis: A recent progress
Karthik Shree Harini, Devaraj Ezhilarasan
Journal of Drug Delivery Science and Technology (2024) Vol. 93, pp. 105467-105467
Closed Access | Times Cited: 5
Karthik Shree Harini, Devaraj Ezhilarasan
Journal of Drug Delivery Science and Technology (2024) Vol. 93, pp. 105467-105467
Closed Access | Times Cited: 5
Impact of Endocrine Disruptors on Key Events of Hepatic Steatosis in HepG2 Cells
M Grosso, Eliška Řehůřková, Ishita Virmani, et al.
Food and Chemical Toxicology (2025), pp. 115241-115241
Closed Access
M Grosso, Eliška Řehůřková, Ishita Virmani, et al.
Food and Chemical Toxicology (2025), pp. 115241-115241
Closed Access
Wnt signaling pathways in biology and disease: mechanisms and therapeutic advances
Xue Chen, Qingfei Chu, Qingmiao Shi, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Xue Chen, Qingfei Chu, Qingmiao Shi, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Investigations on the dysregulated genes in high-fat-fed mice infected with Prevotella intermedia and their possible role in the development of hepatocellular carcinoma
Yathin Reddy Putta, Anitha Pandi, Vijayashree Priyadharsini Jayaseelan
Folia Medica (2025) Vol. 67, Iss. 2
Open Access
Yathin Reddy Putta, Anitha Pandi, Vijayashree Priyadharsini Jayaseelan
Folia Medica (2025) Vol. 67, Iss. 2
Open Access
Hepatocellular carcinoma: pathogenesis, molecular mechanisms, and treatment advances
Zhiyong Ding, Lusheng Wang, Jiting Sun, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Zhiyong Ding, Lusheng Wang, Jiting Sun, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
MAP17 is a Novel NASH Progression Biomarker Associated with Macrophage Infiltration, Immunotherapy Response, and Oxidative Stress
Zhiwei Huang, Jiatong Chen, Shenglu Liu, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 601-619
Open Access
Zhiwei Huang, Jiatong Chen, Shenglu Liu, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 601-619
Open Access
Downregulation of S100 calcium-binding A4 (S100A4) ameliorates hepatic fibrosis <i>via</i> regulating Wnt/β-catenin signaling pathway
Chi‐Xian Zhang, Kai Bai, Dexu Li
European Journal of Histochemistry (2025) Vol. 69, Iss. 2
Open Access
Chi‐Xian Zhang, Kai Bai, Dexu Li
European Journal of Histochemistry (2025) Vol. 69, Iss. 2
Open Access
Identification of diagnostic gene signatures and molecular mechanisms for non-alcoholic fatty liver disease and Alzheimer’s disease through machine learning algorithms
Liqing Jiang, Qian Wang, Yingsong Jiang, et al.
Clinica Chimica Acta (2024) Vol. 557, pp. 117892-117892
Open Access | Times Cited: 3
Liqing Jiang, Qian Wang, Yingsong Jiang, et al.
Clinica Chimica Acta (2024) Vol. 557, pp. 117892-117892
Open Access | Times Cited: 3
SLC13A3 is a major effector downstream of activated β-catenin in liver cancer pathogenesis
Wennan Zhao, Xue Wang, Lifeng Han, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Wennan Zhao, Xue Wang, Lifeng Han, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Anti-osteoporotic treatments in the era of non-alcoholic fatty liver disease: friend or foe
Maria Chondrogianni, Ioannis Kyrou, Θεόδωρος Ανδρουτσάκος, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 2
Maria Chondrogianni, Ioannis Kyrou, Θεόδωρος Ανδρουτσάκος, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 2
Comprehensive Strategy for Identifying Extracellular Vesicle Surface Proteins as Biomarkers for Non-Alcoholic Fatty Liver Disease
Nahuel Aquiles García, Maiken Mellergaard, Hernán González‐King, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13326-13326
Open Access | Times Cited: 5
Nahuel Aquiles García, Maiken Mellergaard, Hernán González‐King, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13326-13326
Open Access | Times Cited: 5
Mechanism and Progress of Natural Products in the Treatment of NAFLD-Related Fibrosis
Jin-Zhong Li, Ning Chen, Nan Ma, et al.
Molecules (2023) Vol. 28, Iss. 23, pp. 7936-7936
Open Access | Times Cited: 5
Jin-Zhong Li, Ning Chen, Nan Ma, et al.
Molecules (2023) Vol. 28, Iss. 23, pp. 7936-7936
Open Access | Times Cited: 5
Identification of disease-related genes and construction of a gene co-expression database in non-alcoholic fatty liver disease
Hua Ye, Mengxia Sun, Mingli Su, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 4
Hua Ye, Mengxia Sun, Mingli Su, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 4
Bombinin-BO1 induces hepatocellular carcinoma cell-cycle arrest and apoptosis via the HSP90A-Cdc37-CDK1 axis
Xiaoting Wang, Peiyu Tang, Yitong Gong, et al.
iScience (2024) Vol. 27, Iss. 8, pp. 110382-110382
Open Access | Times Cited: 1
Xiaoting Wang, Peiyu Tang, Yitong Gong, et al.
iScience (2024) Vol. 27, Iss. 8, pp. 110382-110382
Open Access | Times Cited: 1
Talauromides A–G, Nitrogen-Containing Heptacyclic Oligophenalenone Dimers from the Soil Fungus Talaromyces stipitatus BMC-16
Shikun Zong, Yi-Xuan Zhang, Jun Xiao, et al.
Journal of Natural Products (2024) Vol. 87, Iss. 10, pp. 2450-2458
Closed Access | Times Cited: 1
Shikun Zong, Yi-Xuan Zhang, Jun Xiao, et al.
Journal of Natural Products (2024) Vol. 87, Iss. 10, pp. 2450-2458
Closed Access | Times Cited: 1
Pioneer Factor Foxa2 Mediates Chromatin Conformation Changes for Activation of Bile Acid Targets of FXR
Yi Hao, Lu Han, Anqi Wu, et al.
Cellular and Molecular Gastroenterology and Hepatology (2023) Vol. 17, Iss. 2, pp. 237-249
Open Access | Times Cited: 3
Yi Hao, Lu Han, Anqi Wu, et al.
Cellular and Molecular Gastroenterology and Hepatology (2023) Vol. 17, Iss. 2, pp. 237-249
Open Access | Times Cited: 3
Comprehensive Strategy for Identifying Extracellular Vesicle Surface Proteins as Biomarkers for Non-alcoholic Fatty Liver Disease
Nahuel Aquiles García, Maiken Mellergaard, Hernán González‐King, et al.
(2023)
Open Access | Times Cited: 2
Nahuel Aquiles García, Maiken Mellergaard, Hernán González‐King, et al.
(2023)
Open Access | Times Cited: 2
Signaling pathways that activate hepatic stellate cells during liver fibrosis
Youtian Zhang, Long Ren, Yinting Tian, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access
Youtian Zhang, Long Ren, Yinting Tian, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access
OTUD7B inhibited hepatic injury from NAFLD by inhibiting K48-linked ubiquitination and degradation of β-catenin
Jing Sun, Xiuli Jin, Yiling Li
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1871, Iss. 1, pp. 167555-167555
Closed Access
Jing Sun, Xiuli Jin, Yiling Li
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1871, Iss. 1, pp. 167555-167555
Closed Access
SOX9 Overexpression Ameliorates Metabolic Dysfunction-associated Steatohepatitis Through Activation of the AMPK Pathway
Juan Deng, Kai Ding, Shuqing Liu, et al.
Journal of Clinical and Translational Hepatology (2024) Vol. 000, Iss. 000, pp. 000-000
Open Access
Juan Deng, Kai Ding, Shuqing Liu, et al.
Journal of Clinical and Translational Hepatology (2024) Vol. 000, Iss. 000, pp. 000-000
Open Access
Coleus vettiveroides Root Extract Protects Against Thioacetamide‐Induced Chronic Liver Injury by Inhibiting NF ‐κB Signaling Pathway
Kadmad Abdul Hameed Mohamed Azar, Devaraj Ezhilarasan, M Karthick, et al.
Environmental Toxicology (2024)
Closed Access
Kadmad Abdul Hameed Mohamed Azar, Devaraj Ezhilarasan, M Karthick, et al.
Environmental Toxicology (2024)
Closed Access